Mutations in ANXA11 are associated with ALS, a neurodegenerative disease in which dysfunction of lysosomal and RNA granule biology play causal roles (Smith et al., 2017, Tsai et al., 2018, Zhang et al., 2018a). Here, ANXA11 is linked to amyotrophic lateral sclerosis.